Tag: branded generics market growth

  • Branded Generics Market Growth Potential: Key Insights for 2024-2033

    Branded Generics Market Growth Potential: Key Insights for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Will the Branded Generics Market Grow from 2024 to 2033?

    In the past few years, there has been a significant growth in the size of the branded generics market. The market value is expected to increase from $335.98 billion in 2023 to $367.67 billion in 2024, with a compound annual growth rate (CAGR) of 9.4%. The surge during this period can be accredited to factors such as cost-effectiveness, patent terminations, market accessibility and expansion, governmental strategies and policies, as well as healthcare reforms.

    The market size for branded generics is projected to increase swiftly in the upcoming years. By 2028, it is anticipated to reach $542.32 billion, exhibiting a compound annual growth rate (CAGR) of 10.2%. Factors like rising demand for generic biologics, an increase in chronic diseases, developing markets, and emphasis on biosimilars contribute to this expected growth in the forecast period. Prevailing trends for the same period consist of strategic alliances and collaborations, advancements in technology, emphasis on chronic illnesses, market amalgamation, and patient-oriented strategies.

    Claim Your Free Sample of the Global Branded Generics Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=7186&type=smp

    What Aspects Are Influencing the Growth Rate of the branded generics Market?

    The rising number of chronic diseases is set to propel the growth of the branded generics market. Chronic diseases, while often incurable, can be managed and kept under control. The growth in chronic diseases can often be attributed to factors such as increased use of tobacco, lack of adequate nutrition, physical non-activity, heavy alcohol intake, and more. Branded generics have become the preferred choice of patients across the globe to handle chronic diseases, due to their affordability compared to conventional medicines. In the World Health Organization (WHO) 2022 Highlights report in September 2022, it’s mentioned that 41 million deaths – a whopping 74% of all deaths worldwide – are due to noncommunicable diseases (NCDs) or chronic diseases each year. Hence, the growing prevalence of chronic diseases is anticipated to elevate the demand for branded generics in the predicted period.

    What Are the Critical Segments of the Branded Generics Market?

    1) By Drug Class: Alkylating Agents, Antimetabolites, Hormones, Anti-hypertensive, Lipid Lowering Drugs, Anti-depressants, Anti-psychotics, Anti-Epileptics, Other Drugs

    2) By Route of Administration: Topical, Oral, Parenteral, Other Routes of Administration

    3) By Application: Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-inflammatory, Other Applications

    What Trends Are Redefining Consumer Expectations in the Branded Generics Market?

    Trend 1:

    Forming strategic alliances is a major trend in the branded generics market. Companies in this sector are teaming up with relevant businesses to capitalize on each other’s strengths and break into new markets. One such collaboration occurred in December 2021, when Biocon Ltd., a fully consolidated Indian biopharmaceutical corporation specializing in low-cost biosimilars, generic formulations and complex APIs, partnered with Tabuk Pharmaceuticals. This alliance paves the way for Biocon to make inroads into the MENA region, encompassing Jordan, Lebanon, Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Oman, and Iraq. It will aid in the development of a strong global product portfolio, either directly or via strategic partnerships, enabling patients worldwide to receive affordable treatments. Tabuk Pharmaceuticals, a Saudi Arabian firm that produces and sells branded and generic pharmaceutical goods, will hold the marketing rights for these drugs while also handling their registration, import, and advertisement in Saudi Arabia and other Middle Eastern countries.

    Order Now for Fast Delivery of Your Branded Generics Market Report!

    https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report

    What Are the Leading Regions in the Branded Generics Market Expansion?

    North America was the largest region in the branded generics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the branded generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Branded Generics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the branded generics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Branded Generics Market Include

    1. Branded Generics Market Executive Summary

    2. Branded Generics Market Segments

    3. Branded Generics Market Size And Template Market Growth Rate

    4. Key Branded Generics Market Trends

    5. Major Branded Generics Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Branded Generics Market

    26. Top Branded Generics Companies

    27. Branded Generics Market Opportunities And Strategies

    28. Branded Generics Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Gastrointestinal Drugs Global Market Report 2022

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

    Pharmacies and Drug Stores Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

    Vitamin and Minerals Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/vitamin-and-mineral-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Top 5 Insights From The Branded Generics Market Report 2024

    Top 5 Insights From The Branded Generics Market Report 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Branded Generics Global Market Report 2024, the branded generics market is expected to show promising growth in the forecast period.

    The branded generics market has witnessed remarkable growth in recent years, driven by factors such as affordability, chronic disease prevalence, and strategic partnerships. This blog explores the market’s trajectory, future outlook, key trends, and notable developments shaping the landscape of branded generics.

    Market Overview

    • Current Market Size:
      • Surged from $335.98 billion in 2023 to $367.67 billion in 2024.
      • Compound annual growth rate (CAGR) of 9.4%, indicating robust expansion.
      • Driven by cost savings, patent expiries, and government policies promoting accessibility.

    Future Projections

    • Expected Growth:
      • Projected to reach $542.32 billion by 2028.
      • Forecasted CAGR of 10.2%, reflecting rapid growth fueled by various factors.

    Chronic Disease Epidemic

    • Rising Prevalence of Chronic Diseases:
      • Increasing incidence due to lifestyle factors like poor nutrition and physical inactivity.
      • Customers prefer branded generics for chronic disease management due to affordability.
      • Example: Noncommunicable diseases (NCDs) account for 74% of global deaths annually.

    View More On The Branded Generics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report

    Notable Companies

    • Key Players:
      • Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and others.
      • Driving market growth through innovation and strategic alliances.

    Strategic Partnerships

    • Driving Market Access and Growth:
      • Key trend in the branded generics market.
      • Companies forming partnerships to expand into new markets and leverage resources.
      • Example: Biocon Ltd. partnering with Tabuk Pharmaceuticals to enter the MENA region.

    Strategic Acquisitions

    • Expanding Product Portfolios:
      • Reddy’s Laboratories’ acquisition of branded and generic injectable products from Eton Pharmaceuticals, Inc.
      • Aims to enhance product offerings and accelerate market presence in key segments.

    Market Segmentation

    • Drug Classes:
      • Alkylating Agents, Antimetabolites, Hormones, Anti-hypertensive, and more.
    • Routes of Administration:
      • Topical, Oral, Parenteral, and Other Routes.
    • Applications:
      • Oncology, Cardiovascular Diseases, Diabetes, Neurology, and more.

    Regional Insights

    • North America:
      • Largest region in the branded generics market in 2023.
      • Driven by established healthcare infrastructure and market demand.
    • Asia-Pacific:
      • Expected to be the fastest-growing region.
      • Rising healthcare expenditure and expanding market access drive growth.

    Emerging Trends

    • Technological Advancements:
      • Continued innovation in drug delivery systems and formulations.
    • Focus on Chronic Diseases:
      • Increasing emphasis on developing treatments for chronic conditions.
    • Market Consolidation:
      • Growing consolidation through mergers and acquisitions to enhance market position.
    • Patient-Centric Approach:
      • Shift towards personalized medicine and patient-focused healthcare solutions.

    The branded generics market is on a trajectory of significant growth, driven by factors such as chronic disease prevalence, strategic partnerships, and market expansion initiatives. As the market continues to evolve, stakeholders must adapt to emerging trends and regulatory landscapes to capitalize on the abundant opportunities within this dynamic sector.

    Request A Sample Of The Global Branded Generics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=7186&type=smp